TABLE 3.
Sample no. | Final endpoint titera |
|
---|---|---|
Architect assay | IFA test | |
1 | 1:80 | <1:64 |
2 | 1:320 | <1:64 |
3 | 1:5,120 | 1:512 |
4 | 1:640 | 1:128 |
5b | Negative | <1:64 |
6 | 1:1,280 | 1:512 |
7 | 1:160 | <1:64 |
8 | 1:40 | <1:64 |
9 | 1:2,560 | 1:512 |
Each sample comprises a pool of IFA-reactive donors. For the anti-Babesia assay, the dilution shown is the last value to be considered positive in the assay (S/CO of >1.0). For samples detected by IFA, the titer indicated is the endpoint titer, and samples with titers of <1:64 are considered negative.
Sample 5 was a negative control.